Hebei Jianxin Chemical Past Earnings Performance
Past criteria checks 1/6
Hebei Jianxin Chemical's earnings have been declining at an average annual rate of -62.9%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 4.1% per year. Hebei Jianxin Chemical's return on equity is 1.2%, and it has net margins of 2.8%.
Key information
-62.9%
Earnings growth rate
-63.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -4.1% |
| Return on equity | 1.2% |
| Net Margin | 2.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Hebei Jianxin Chemical's (SZSE:300107) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 01
Weak Statutory Earnings May Not Tell The Whole Story For Hebei Jianxin Chemical (SZSE:300107)
May 01Recent updates
Hebei Jianxin Chemical's (SZSE:300107) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 01Hebei Jianxin Chemical Co., Ltd.'s (SZSE:300107) Shares Climb 25% But Its Business Is Yet to Catch Up
Sep 30Hebei Jianxin Chemical Co., Ltd.'s (SZSE:300107) 28% Share Price Plunge Could Signal Some Risk
Jun 10Weak Statutory Earnings May Not Tell The Whole Story For Hebei Jianxin Chemical (SZSE:300107)
May 01Hebei Jianxin Chemical Co., Ltd. (SZSE:300107) Stock Rockets 90% As Investors Are Less Pessimistic Than Expected
Apr 25Hebei Jianxin Chemical Co., Ltd. (SZSE:300107) Stock Rockets 47% As Investors Are Less Pessimistic Than Expected
Mar 07What Hebei Jianxin Chemical Co., Ltd.'s (SZSE:300107) 47% Share Price Gain Is Not Telling You
Mar 07Revenue & Expenses Breakdown
How Hebei Jianxin Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 638 | 18 | 34 | 38 |
| 30 Jun 24 | 699 | 18 | 38 | 42 |
| 31 Mar 24 | 686 | 19 | 42 | 37 |
| 31 Dec 23 | 658 | 15 | 42 | 35 |
| 30 Sep 23 | 657 | 23 | 45 | 30 |
| 30 Jun 23 | 645 | 34 | 47 | 29 |
| 31 Mar 23 | 704 | 54 | 41 | 33 |
| 01 Jan 23 | 742 | 61 | 41 | 32 |
| 30 Sep 22 | 761 | 54 | 47 | 41 |
| 30 Jun 22 | 713 | 42 | 41 | 33 |
| 31 Mar 22 | 634 | 21 | 45 | 26 |
| 01 Jan 22 | 628 | 14 | 50 | 28 |
| 30 Sep 21 | 561 | -3 | 54 | 18 |
| 30 Jun 21 | 548 | -3 | 53 | 21 |
| 31 Mar 21 | 565 | 22 | 52 | 25 |
| 31 Dec 20 | 564 | 45 | 53 | 25 |
| 30 Sep 20 | 605 | 100 | 50 | 25 |
| 30 Jun 20 | 700 | 170 | 59 | 30 |
| 31 Mar 20 | 789 | 245 | 64 | 33 |
| 31 Dec 19 | 925 | 326 | 67 | 38 |
| 30 Sep 19 | 1,107 | 445 | 70 | 47 |
| 30 Jun 19 | 1,309 | 583 | 80 | 42 |
| 31 Mar 19 | 1,439 | 651 | 85 | 54 |
| 01 Jan 19 | 1,418 | 656 | 86 | 49 |
| 30 Sep 18 | 1,226 | 546 | 87 | 37 |
| 30 Jun 18 | 944 | 351 | 65 | 48 |
| 31 Mar 18 | 710 | 196 | 58 | 24 |
| 31 Dec 17 | 536 | 87 | 54 | 17 |
| 30 Sep 17 | 448 | 40 | 36 | 16 |
| 30 Jun 17 | 372 | 30 | 47 | 0 |
| 31 Mar 17 | 334 | 23 | 48 | 0 |
| 31 Dec 16 | 331 | 23 | 46 | 0 |
| 30 Sep 16 | 362 | 25 | 49 | 0 |
| 30 Jun 16 | 399 | 25 | 52 | 0 |
| 31 Mar 16 | 418 | 22 | 51 | 0 |
| 31 Dec 15 | 416 | 23 | 50 | 0 |
| 30 Sep 15 | 420 | 18 | 43 | 0 |
| 30 Jun 15 | 430 | 20 | 51 | 0 |
| 31 Mar 15 | 446 | 30 | 52 | 0 |
| 31 Dec 14 | 466 | 41 | 52 | 0 |
| 30 Sep 14 | 466 | 51 | 55 | 0 |
| 30 Jun 14 | 468 | 63 | 49 | 0 |
| 31 Mar 14 | 421 | 48 | 48 | 0 |
| 31 Dec 13 | 411 | 36 | 52 | 0 |
Quality Earnings: 300107 has high quality earnings.
Growing Profit Margin: 300107's current net profit margins (2.8%) are lower than last year (3.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300107's earnings have declined by 62.9% per year over the past 5 years.
Accelerating Growth: 300107's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300107 had negative earnings growth (-23.6%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).
Return on Equity
High ROE: 300107's Return on Equity (1.2%) is considered low.